Wattle Health Australia Ltd share price rockets 7% higher on Chinese distribution deal

The Wattle Health Australia Ltd (ASX: WHA) share price has shot higher this morning by 7% on some Chinese news.

Wattle Health has signed a ‘term sheet’ with International Supplies and Distribution Company Pty Ltd (ISDC) for supplying the China market.

The infant formula company said that ISDC has guaranteed minimum annual volumes to supply the Chinese market, it has committed a bank guarantee to secure Wattle Health’s supply.

Wattle Health said that finalisation of the distribution arrangement is subject to finalisation of CFDA accreditation and finalisation of the formal supply agreement. In other words, it isn’t 100% confirmed yet.

Under the agreement ISDC has guaranteed to purchase a minimum of 1.5 million units in the first 18 months, then a further 1.5 million units in the next 12 months and then 2.2 million units in the following 12 months.

After the above three and a half years Wattle Health and ISDC will set new volumes for future 12 month periods.

ISDC has agreed to provide Wattle Health a bank guarantee of an amount equivalent to 25% of the production cost. The minimum value targets with ISDC are in addition to Wattle Health’s arrangements with existing customers.

Wattle Health’s Executive Chairman, Lazarus Karasavvidis, said “This agreement with ISDC is an important milestone for Wattle Health Australia which enables us to grow our footprint in Mainland China.

“Further, this Agreement provides Wattle Health Australia minimum volume levels, which enable the Company to forward plan with confidence as we look to expand our product offerings not just in China but globally. Wattle Health Australia welcomes ISDC to the Wattle Health Family and we look forward to a long term mutually beneficial relationship.”

Foolish takeaway

Guaranteed volume sales is obviously a good thing for Wattle Health, although it depends what price Wattle Health is able to get for its products.

There is a lot of excitement and expectation built into Wattle Health’s share price, so this would go some distance to justify the value. However, I wouldn’t buy at today’s price until the company has reported sustainable profit growth.

Instead, I’d rather put my investing money towards these top growth stocks.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.